뉴스

• i-SENS Soars on Earnings, Peptron Rebounds, Cellid Hits Limit-Up[K-Bio Pulse] South Korean pharmaceutical and biotechnology stocks were mixed Monday, with i-SENS soaring after reporting second quarter earnings that far exceeded market expectations, Peptron extending its reboun... www.edaily.co.kr · 2026.07.28
• Remedi Surges, HLB Hits Limit Down as FDA Blow Weighs[K-Bio Pulse] The Korean biotech sector saw sharply diverging performances on July 13, with newly listed Remedi. emerging as the day's standout performer, while HLB extended its selloff following another U.S. www.edaily.co.kr · 2026.07.14
• Antrogen Slides on Japan Fears, Hanmi Science Gains[K-Bio Pulse] South Korean biopharmaceutical stocks moved in opposite directions on Tuesday, with Antrogen tumbling to the daily limit on concerns over the commercial potential of its regenerative medicine product... www.edaily.co.kr · 2026.07.09
• [WT논평] Iran is trying to turn America against Israel(Ⅰ) Vance was heading to Switzerland to lead up new peace talks with Iran about its pursuit of nuclear weapons www.segye.com · 2026.06.28
• STARTRADER, 반도체-광네트워킹-원자력 분야 31개 신규 미국 주식 및 ETF CFD로 AI 상품군 확대 STARTRADER Expands Its AI Infrastructure Offering with 31 New US Share CFDs and ETF CFDs Across Semiconductors zdnet.co.kr · 2026.08.14